Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07356050 · ClinicalTrials.gov registry record
Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease
A clinical trial of Sickle Cell Disease and Sickle Cell Anemia, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 130
- Enrollment target
- 3
- Study locations
NCT07356050 is a study of Sickle Cell Disease and Sickle Cell Anemia that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 130 participants, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (55% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT07356050, a study of Sickle Cell Disease and Sickle Cell Anemia, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 130 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this study is to learn if infants with sickle cell disease (SCD) develop adequate protection after measles vaccines. (not looking at any prolonged duration)
Conditions Studied
Study Locations (3)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Ghana
- Korle Bu Teaching Hospital - Accra
Other
- Bugando Medical Centre - Mwanza
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2025-03-13 |
| Est. Completion | 2028-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07356050
The ClinicalTrials.gov registry entry for NCT07356050 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (55% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 0 interventions.
NCT07356050 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Ohio, Ghana, Other.
Frequently Asked Questions
What is clinical trial NCT07356050 about?
NCT07356050 is a clinical study titled "Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease". The goal of this study is to learn if infants with sickle cell disease (SCD) develop adequate protection after measles vaccines. (not looking at any prolonged duration)
What is the current status of trial NCT07356050?
This trial is currently recruiting. The enrollment target is 130 participants. The study started on 2025-03-13. Estimated completion is 2028-12-31.
What conditions does trial NCT07356050 study?
This clinical trial studies the following conditions: Sickle Cell Disease, Sickle Cell Anemia, Measles Vaccination.
Who is sponsoring clinical trial NCT07356050?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07356050 being conducted?
This trial has 3 study locations across Ohio, Ghana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
RECRUITING · Phase 2
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
RECRUITING · Phase 1
-
Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.